On ECHEMI
Home > Drugs > Risedronate sodium Registered Holders
Risedronate sodium structure

Risedronate sodium structure

Risedronate sodium

Fine White to Off-White Crystalline PowderRisedronate sodium is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Risedronate sodium is used for the treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures, treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures, treatment of osteoporosis in men at high risk of fractures, and treatment of Paget’s disease.

Find 13 Related Holders

Topfond Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2013-11-13
  • Country:

    China China
  • Address:

    No. 2 Guangming Road, Yicheng District, Zhumadian City
  • Tax NO.:

    91411700083473072R
  • Registered Funds:

    420 million yuan
  • Website:

  • Email:

Beijing SL Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    1994-12-24
  • Country:

    China China
  • Address:

    4th Floor, Building 1, Bitongyuan, No. 69, Fushi Road, Haidian District, Beijing
  • Tax NO.:

    91110000102299779W
  • Registered Funds:

    1,027.35 million yuan
  • Website:

  • Email:

DIVIS LABORATORIES LTD
United States United States

API Registration Country

API Inactive
  • 1
  • 2
  • Go to Page Go
Recommended Suppliers of Risedronate sodium
View 35 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.